The Effect of Testosterone on Cardiovacular Biomarkers in the Testosterone Trials.

Conclusions and Relevance: Testosterone treatment for one year of older men with low testosterone was associated with small reductions in cholesterol and insulin but not with other glucose markers or markers of inflammation or fibrinolysis or with troponin. The clinical importance of these findings is unclear and requires a larger trial of clinical outcomes.
PMID: 29253154 [PubMed - as supplied by publisher]

Source: The Journal of Clinical Endocrinology and Metabolism - December 14, 2017 Category: Endocrinology Authors: Mohler ER, Ellenberg SS, Lewis CE, Wenger NK, Budoff MJ, Lewis MR, Barrett-Connor E, Swerdloff RS, Stephens-Shields A, Bhasin S, Cauley JA, Crandall JP, Cunningham GR, Ensrud KE, Gill TM, Matsumoto AM, Molitch ME, Pahor M, Preston PE, Hou X, Cifelli D, Sn Tags: J Clin Endocrinol Metab Source Type: research